N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine

C94H116FN17 — CID 157364071

IUPACN,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine
SMILESCc1ccc2c(c1)c1c(n2CC(C)(c2cnccn2)N(C)C)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(N)c2ccncc2)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(c2ccc(F)cc2)N(C)C)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(c2cnccn2)N(C)C)CCN2CCCC12
InChIInChI=1S/C25H30FN3.C24H31N5.C23H29N5.C22H26N4/c1-17-6-11-21-20(15-17)25-22-5-4-13-28(22)14-12-23(25)29(21)16-24(27(2)3)18-7-9-19(26)10-8-18;1-17-7-8-19-18(14-17)23-20-6-5-12-28(20)13-9-21(23)29(19)16-24(2,27(3)4)22-15-25-10-11-26-22;1-16-6-7-19-17(13-16)23-20-5-4-11-27(20)12-8-21(23)28(19)15-22(26(2)3)18-14-24-9-10-25-18;1-15-4-5-19-17(13-15)22-20-3-2-11-25(20)12-8-21(22)26(19)14-18(23)16-6-9-24-10-7-16/h6-11,15,22,24H,4-5,12-14,16H2,1-3H3;7-8,10-11,14-15,20H,5-6,9,12-13,16H2,1-4H3;6-7,9-10,13-14,20,22H,4-5,8,11-12,15H2,1-3H3;4-7,9-10,13,18,20H,2-3,8,11-12,14,23H2,1H3
InChIKeyBIYZPILXDGUCJM-UHFFFAOYSA-N
MW1503.08 g/mol
LogP16.47
Rot. Bonds15

About N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine

N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine (PubChem CID 157364071) has the molecular formula C94H116FN17 and a molecular weight of 1503.08 g/mol. Its IUPAC name is N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine.

Molecular Properties

Compound NameN,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine
PubChem CID157364071
Molecular FormulaC94H116FN17
Molecular Weight1503.08 g/mol
Exact Mass1501.96
IUPAC NameN,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine
SMILESCc1ccc2c(c1)c1c(n2CC(C)(c2cnccn2)N(C)C)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(N)c2ccncc2)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(c2ccc(F)cc2)N(C)C)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(c2cnccn2)N(C)C)CCN2CCCC12
InChIInChI=1S/C25H30FN3.C24H31N5.C23H29N5.C22H26N4/c1-17-6-11-21-20(15-17)25-22-5-4-13-28(22)14-12-23(25)29(21)16-24(27(2)3)18-7-9-19(26)10-8-18;1-17-7-8-19-18(14-17)23-20-6-5-12-28(20)13-9-21(23)29(19)16-24(2,27(3)4)22-15-25-10-11-26-22;1-16-6-7-19-17(13-16)23-20-5-4-11-27(20)12-8-21(23)28(19)15-22(26(2)3)18-14-24-9-10-25-18;1-15-4-5-19-17(13-15)22-20-3-2-11-25(20)12-8-21(22)26(19)14-18(23)16-6-9-24-10-7-16/h6-11,15,22,24H,4-5,12-14,16H2,1-3H3;7-8,10-11,14-15,20H,5-6,9,12-13,16H2,1-4H3;6-7,9-10,13-14,20,22H,4-5,8,11-12,15H2,1-3H3;4-7,9-10,13,18,20H,2-3,8,11-12,14,23H2,1H3
InChIKeyBIYZPILXDGUCJM-UHFFFAOYSA-N
XLogP16.47
TPSA132.87 Ų
H-Bond Donors1
H-Bond Acceptors17
Rotatable Bonds15
Heavy Atoms112
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001503.08
LogP ≤ 516.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine?
The IUPAC name of N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine (CID 157364071) is N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine.
What is the SMILES notation for N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine?
The canonical SMILES for N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine is Cc1ccc2c(c1)c1c(n2CC(C)(c2cnccn2)N(C)C)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(N)c2ccncc2)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(c2ccc(F)cc2)N(C)C)CCN2CCCC12.Cc1ccc2c(c1)c1c(n2CC(c2cnccn2)N(C)C)CCN2CCCC12.
What is the InChIKey of N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine?
The InChIKey is BIYZPILXDGUCJM-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H30FN3.C24H31N5.C23H29N5.C22H26N4/c1-17-6-11-21-20(15-17)25-22-5-4-13-28(22)14-12-23(25)29(21)16-24(27(2)3)18-7-9-19(26)10-8-18;1-17-7-8-19-18(14-17)23-20-6-5-12-28(20)13-9-21(23)29(19)16-24(2,27(3)4)22-15-25-10-11-26-22;1-16-6-7-19-17(13-16)23-20-5-4-11-27(20)12-8-21(23)28(19)15-22(26(2)3)18-14-24-9-10-25-18;1-15-4-5-19-17(13-15)22-20-3-2-11-25(20)12-8-21(22)26(19)14-18(23)16-6-9-24-10-7-16/h6-11,15,22,24H,4-5,12-14,16H2,1-3H3;7-8,10-11,14-15,20H,5-6,9,12-13,16H2,1-4H3;6-7,9-10,13-14,20,22H,4-5,8,11-12,15H2,1-3H3;4-7,9-10,13,18,20H,2-3,8,11-12,14,23H2,1H3.
What are the key properties of N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine?
N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine has a molecular weight of 1503.08 g/mol, XLogP of 16.47, 15 rotatable bonds, 1 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyrazin-2-ylethanamine;N,N-dimethyl-1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-amine;1-(4-fluorophenyl)-N,N-dimethyl-2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)ethanamine;2-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-4-ylethanamine is sourced from PubChem (CID 157364071), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).